✦ LIBER ✦

Analysis of direct cost of standard compared with intensive insulin treatment of insulin-dependent diabetes mellitus and cost of complications

✍ Scribed by Z. Stern; R. Levy

Publisher: Springer
Year: 1996
Tongue: English
Weight: 572 KB
Volume: 33
Category: Article
ISSN: 0940-5429
DOI: 10.1007/bf00571940

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effectiveness and cost-benefit analysis

Effectiveness and cost-benefit analysis of intensive treatment and teaching programmes for Type 1 (insulin-dependent) diabetes mellitus in Moscow—blood glucose versus urine glucose self-monitoring

✍ E. G. Starostina; M. Antsiferov; G. R. Galstyan; Ch. Trautner; V. Jörgens; U. Bo 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 850 KB

Terbinafine (Lamisil®) treatment of toen

Terbinafine (Lamisil®) treatment of toenail onychomycosis in patients with insulin-dependent and non-insulin-dependent diabetes mellitus: a multicentre trial

✍ B. Farkas; C. Paul; A. Dobozy; J. Hunyadi; A. Horváth; G. Fekete 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB

Risk of adverse effects of intensified t

Risk of adverse effects of intensified treatment in insulin-dependent diabetes mellitus: a meta-analysis

✍ Egger, M.; Davey Smith, G.; Stettler, C.; Diem, P. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 2 views

While the benefits of intensified insulin treatment in insulin-dependent (Type 1) diabetes mellitus (IDDM) are well recognized, the risks have not been comprehensively characterized. We examined the risk of severe hypoglycaemia, ketoacidosis, and death in a meta-analysis of randomized controlled tri

Clinical importance of insulin secretion

Clinical importance of insulin secretion and its interaction with insulin resistance in the treatment of type 2 diabetes mellitus and its complications

✍ Daniel Porte; Jr 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 1 views

Pravastatin compared to bezafibrate in t

Pravastatin compared to bezafibrate in the treatment of dyslipidemia in insulin-treated patients with Type 2 diabetes mellitus

✍ C. Rustemeijer; J. A. Schouten; H. J. Voerman; H. E. S. J. Hensgens; A. J. M. Do 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 2 views

Background Both HMG-CoA reductase inhibitors and ®bric acid derivates are used for the treatment of dyslipidemia in Type 2 diabetes patients. The aim of this study was to compare the lipid lowering effect of 40 mg pravastatin, a HMG-CoA reductase inhibitor, and 400 mg beza®brate, a ®bric acid deriva

Health-related quality of life in relati

✍ K. Wikblad; J. Leksell; L. Wibell 📂 Article 📅 1996 🏛 Springer Netherlands 🌐 English ⚖ 760 KB